Fragile X-associated tremor ataxia syndrome (FXTAS) results from a CGG repeat expansion in the 5 0 UTR of FMR1. This repeat is thought to elicit toxicity as RNA, yet disease brains contain ubiquitin-positive neuronal inclusions, a pathologic hallmark of protein-mediated neurodegeneration. We explain this paradox by demonstrating that CGG repeats trigger repeat-associated non-AUG-initiated (RAN) translation of a cryptic polyglycine-containing protein, FMRpolyG. FMRpolyG accumulates in ubiquitin-positive inclusions in Drosophila, cell culture, mouse disease models, and FXTAS patient brains. CGG RAN translation occurs in at least two of three possible reading frames at repeat sizes ranging from normal (25) to pathogenic (90), but inclusion formation only occurs with expanded repeats. In Drosophila, CGG repeat toxicity is suppressed by eliminating RAN translation and enhanced by increased polyglycine protein production. These studies expand the growing list of nucleotide repeat disorders in which RAN translation occurs and provide evidence that RAN translation contributes to neurodegeneration.
INTRODUCTION
A diverse group of human neurological disorders result from nucleotide repeat expansions (Orr and Zoghbi, 2007) . These mutations can cause disease by protein gain-of-function, protein loss-of-function, or RNA gain-of-function mechanisms. For dominantly inherited repeat expansion disorders, defining whether the gain-of-function toxicity is elicited as RNA or as protein has traditionally depended on whether the repeat resides in an open reading frame (ORF) within an exon. For example, in Huntington's disease and other polyglutamine neurodegenerative disorders, expansion of exonic CAG repeats encoding polyglutamine promotes aggregation and alterations in the native properties of disease proteins (Orr and Zoghbi, 2007) . In contrast, in myotonic dystrophy type 1, a CUG repeat expansion in the 3 0 UTR of the DMPK gene causes toxicity predominantly as RNA (Cooper et al., 2009 ). The CUG repeat forms a hairpin structure that binds and sequesters certain splicing factors while also triggering activation of other pathogenic cascades.
Recently, however, the line separating RNA and protein gainof-function nucleotide repeat diseases has begun to blur. RNAmediated toxicity has now been proposed to contribute to polyglutamine diseases and bidirectional transcription through expansions can lead to repeats in both ''coding'' and ''noncoding'' mRNAs, raising the possibility that multiple toxic species may be produced from a single expansion (Ladd et al., 2007; Moseley et al., 2006; Wilburn et al., 2011) . Moreover, evidence now suggests that repeats can be translated into proteins even if they do not reside in an AUG-initiated open reading frame (Zu et al., 2011) . This repeat-associated non-AUG-initiated (RAN) translation can occur in all three possible ORFs of a given transcript, leading to numerous potentially toxic entities from a given repeat sequence (Pearson, 2011) . RAN translation was recently shown to occur through the C9orf72 GGGGCC repeat expansion that causes ALS and frontotemporal dementia (Ash et al., 2013; DeJesus-Hernandez et al., 2011; Mori et al., 2013; Renton et al., 2011) . These new findings raise key questions about how RAN translation occurs and whether it contributes directly to neurodegeneration. As the expected mechanisms of toxicity differ depending on whether the inciting agent is RNA or protein, defining the critical toxic species in each repeat expansion disorder is an important step toward therapeutic development.
To explore the respective roles of RNA and RAN translation in repeat-associated neurodegeneration, we investigated fragile X-associated tremor ataxia syndrome (FXTAS), a common inherited cause of gait disorder, dementia, and tremor (Jacquemont et al., 2004) . FXTAS is caused by a modestly expanded CGG nucleotide repeat in the 5 0 UTR of the fragile X mental retardation gene, FMR1. Much larger expansions of the same repeat cause fragile X syndrome, the most common inherited form of mental retardation, by silencing FMR1 transcription (Penagarikano et al., 2007) . By contrast, in FXTAS patients and animal models, the moderately expanded CGG repeat is associated with elevated FMR1 mRNA expression, neurodegeneration, and intranuclear neuronal inclusions that contain the CGG repeat mRNA and various proteins Tassone et al., 2004) . Research to date has focused on how the repeat might trigger neurodegeneration through an RNA mechanism Sellier et al., 2010; Sofola et al., 2007) , but critical aspects of disease pathology are not explained by a purely RNA-mediated process. Notably, the inclusions in FXTAS brains differ from those seen in other RNA-mediated disorders: they are large, ubiquitinated aggregates containing chaperone proteins such as HSP70 and many other proteins that do not interact directly with CGG repeat mRNA Iwahashi et al., 2006) . The inclusions of FXTAS instead more closely resemble neuronal intranuclear inclusions seen in polyglutamine diseases and other proteinmediated neurodegenerative disorders (Williams and Paulson, 2008) .
Here we explain this paradox. We demonstrate that the CGG repeat expansion in FXTAS triggers RAN translational initiation within the 5 0 UTR of FMR1 mRNA through an AUG-independent mechanism. The translated product, a cryptic polyglycinecontaining protein we name FMRpolyG, is toxic in Drosophila and in human cell lines, capable of driving intranuclear inclusion formation, and present in FXTAS patient brains. The ability to produce FMRpolyG also explains pathologic discrepancies between two mouse models of FXTAS and directly influences the toxicity of CGG repeat constructs in Drosophila. Our findings support a disease model in which RAN translation of an expanded polyglycine protein contributes to FXTAS disease pathogenesis and suggest novel approaches toward therapeutic development in this and other neurodegenerative disorders.
RESULTS

Repeat-Associated Non-AUG-Initiated Translation and Inclusion Formation in a Drosophila Model of FXTAS
To explore the mechanism of inclusion formation in FXTAS, we utilized a Drosophila model of CGG repeat-mediated neurodegeneration in which the 5 0 UTR from an FXTAS patient containing 90 CGG repeats is placed upstream of the coding region for GFP ( Figure 1A ; Jin et al., 2003; Todd et al., 2010) . Initially designed to evaluate RNA-mediated toxicity, the (CGG) 90 GFP-expressing flies exhibit repeat length-dependent retinal degeneration (Jin et al., 2003) . Remarkably, GFP-positive inclusions accumulate in (CGG) 90 GFP-expressing flies but not in flies expressing GFP alone ( Figure 1B ). These inclusions form in both the nucleus and cytoplasm and immunostain positively for ubiquitin and the chaperone HSP70 ( Figures 1C and 1D) .
CGG repeat RNA forms foci in FXTAS patients and in cell models of disease (Sellier et al., 2010; Tassone et al., 2004) . We therefore evaluated whether the observed GFP inclusions in (CGG) 90 GFP-expressing flies colocalize with RNA foci. Multiple nuclear and cytoplasmic RNA foci were observed in retinal sections probed with a Cy5-(CCG) 6 RNA probe ( Figure 1E , see Figure S1A available online) (Sellier et al., 2010) . Only a fraction (43%) of RNA foci colocalized with GFP-positive inclusions ( Figure 1F ).
In principle, the GFP inclusions could result from general impairment of the ubiquitin proteasome system (UPS) by CGG repeat-containing mRNA/protein complexes. Arguing against this possibility, however, is the fact that coexpression of the temperature-sensitive b2 proteasomal subunit mutant DTS7 with GFP did not result in GFP inclusions ( Figure S1B and data not shown), whereas it did induce inclusion formation by a more aggregate-prone fluorescent reporter, DsRed ( Figure S1C ). We next crossed flies expressing (CGG) 90 GFP with flies expressing DsRed. In this cross, if GFP inclusions resulted from a general toxic effect of the repeat, then the aggregation-prone DsRed should also form inclusions that coaggregate with GFP. These flies, however, developed GFP-positive inclusions without coaggregation of DsRed, suggesting that inclusion formation requires the CGG repeat to be present in the same mRNA that encodes GFP ( Figure S1D ). The presence of GFP inclusions prompted us to test whether enhancing or suppressing protein quality control pathways could modulate retinal degeneration in (CGG) 90 GFP-expressing flies. Consistent with a proteinmediated effect, retinal degeneration was enhanced by coexpressing the temperature-sensitive proteasomal subunit mutation DTS5 (b6 subunit) and suppressed by coexpression of the chaperone protein HSP-70 ( Figure 1G ; Jin et al., 2003; data not shown) .
A recent report suggests that CAG repeats can trigger unconventional translation initiation (RAN translation) in the absence of an AUG start codon (Zu et al., 2011) . We therefore asked whether CGG repeats trigger RAN translation upstream of, and in frame with, the GFP coding sequence to generate a higher molecular weight (HMW) GFP fusion protein that is prone to aggregate. Indeed, western blot analysis of (CGG) 90 GFP Drosophila lysates revealed an additional GFP species $12 kDa larger than GFP ( Figure 1H , arrow). Sequence analysis ruled out an unexpected upstream ATG mutation in the GFP coding sequence or loss of the GFP stop codon as the basis for this HMW GFP (full sequence is in Figure S1E ). Stringent immunoprecipitations from (CGG) 90 GFP lysates ( Figure S1F ) also excluded ubiquitination as the cause of the HMW GFP protein.
Tandem mass spectroscopy (MS) of GFP immunoprecipitates from (CGG) 90 GFP Drosophila lysates confirmed the presence of an unconventional translation product. Three peptides were identified that correspond to the predicted protein sequence downstream of the repeat if the FMR1 5 0 UTR were translated ( Figure 1I ). These peptides were not detected in flies expressing GFP alone and are not predicted to exist in the Drosophila proteome. Based on the apparent molecular weight of the observed product, the identified peptide sequences corresponding to the 5 0 UTR, and the reading frame of GFP, we conclude that the repeat is translated in the GGC reading frame to produce a 90 amino acid polyglycine stretch at the N terminus of the protein, with translation initiating just 5 0 to the repeat. Consistent with this, further analysis identified a fourth peptide immediately N-terminal to the polyglycine repeat ( Figure 1I ) but no other peptides above this region.
No polyglycine fragment was detected by tandem MS, reflecting the lack of trypsin cleavage sites in expanded polyglycine. To confirm that the translation product contains polyglycine, we treated immunoprecipitates with lysostaphin, a specific pentaglycine endopeptidase (Huber and Schuhardt, 1970) . Lysostaphin successfully cleaved the HMW GFP species from (CGG) 90 GFP lysates but had no effect on GFP alone, confirming the presence of a polyglycine repeat ( Figure 1J ). Zu et al. (2011) Figure 2A , Table S1 ). Importantly, this construct differs from the (CGG) 90 GFP fly sequence in that the GFP start codon resides in the CGG arginine-encoding frame relative to the repeat (specified as +0 in all figures). This frame recapitulates the relationship of the repeat to the FMRP ORF in FMR1 mRNA. In contrast, the GFP start codon in the Drosophila model resides in the GGC glycine-encoding frame (specified as +1 in all figures). For consistency, the repeat is referred to as CGG in all figures regardless of the frame in which it is translated, with modifiers placed before or after the repeat to indicate the relevant ORF and protein product and any introduced sequence changes. The sequences of all constructs are included in Table S1 . Expression of the (CGG) 88 +0 GFP construct led to diffuse GFP expression in transfected cells ( Figure 2B ), as previously reported (Arocena et al., 2005) . To test whether RAN translation might initiate in other reading frames through the repeat, we added one or two bases between the CGG repeat and the ATG start codon of GFP: +1 (GGC, glycine-encoding) and +2 (GCG, alanine-encoding). As in (CGG) 90 GFP flies, the +1 (Gly) frame induced GFP inclusions in COS and SY5Y cells that accumulated over time (Figures 2B and 2D) and were predominantly intranuclear and ubiquitin positive ( Figure 2E ). Predictably, placing a stop codon after the repeat but before the GFP start site blocked GFP inclusion formation in the +1 (Gly) frame (Figure 2B) . Consistent with the lack of an HMW FMRP species in FXTAS patients and animal models, no GFP-positive inclusions were identified in the +0 frame, despite the absence of intervening stop codons between the repeat and the ATG initiation codon of GFP. To test for the appearance of similar RAN translation products in mammalian cells as observed in Drosophila, we performed western blots on cell lysates 72 hr after transfection with each construct. An HMW GFP species was produced only in the +1 (Gly) frame and was no longer produced when a stop codon was placed between the repeat and the GFP start codon ( Figure 2C ). With the (CGG) 88 +1 GFP construct, this HMW GFP species constituted $10% of the total cellular pool of GFP.
RAN Translation Produces a Polyglycine-Containing Protein in Mammalian Cells
In a parallel set of experiments, we generated constructs in which GFP lacked its canonical start codon. As expected, this mutation markedly reduced the production of GFP in transfected cells, but when a 55 CGG repeat sequence was inserted upstream of this ATG-less GFP, placing the repeat in the glycine (+1)-encoding frame relative to GFP, the number of GFP-positive cells recovers to 60% of that seen with ATG-GFP (Figures S2A and S2B). In contrast, placing the CGG repeat in the arginine (+0)-encoding frame did not significantly increase the number of GFP-positive cells (Figures S2A and S2B) . These findings correlated with production of RAN translation products as assessed by western blot: the HMW-GFP protein level was $10% of that produced from GFP alone, while translation products from the +0 (Arg) construct were below the limit of detection ( Figure S2C ).
Studies comparing the aggregation properties of homopolymeric peptides suggest that small stretches of polyglycine are not prone to aggregation (Oma et al., 2004) . To evaluate the aggregation properties of an expanded polyglycine-containing protein in FXTAS, we introduced an ATG start site upstream of the repeat in the glycine frame fused to GFP (ATG-(CGG) 88 +1 GFP). Incorporation of a canonical start site markedly increased production of the HMW GFP ( Figure 2F ), leading to inclusion formation in most cells 24 hr after transfection, which is comparable to the rate of inclusion formation seen when expanded polyglutamine is fused to GFP (Q 80 GFP, Figures 2G and 2H) .
Because the risk of developing FXTAS increases with larger repeats (Leehey et al., 2008) , we evaluated the impact of repeat length on the production and aggregation of HMW GFP. The normal FMR1 repeat in humans is between 20 and 45 CGGs, usually interrupted by one or two intervening AGGs. Constructs with 30, 50, or 88 CGG repeats in the +1 (Gly) frame with GFP all resulted in HMW GFP production ( Figure 3A) . Remarkably, production of the RAN translation product appeared to increase with decreasing repeat size, which may reflect differences in the transfer efficiency to PVDF membrane or greater translational efficiency for GFP and HMW GFP with shorter repeats (Chen et al., 2003) . In contrast, aggregation decreased with decreasing repeat size, such that inclusions were infrequent at 50 repeats and nearly absent at 30 CGG repeats, suggesting a repeat length dependence to aggregation ( Figures 3B and 3C ). This repeat length dependence to inclusion formation was consistent across numerous cell types including primary cortical neurons ( Figure S2D ). Consistent with published studies, longer repeats were also associated with decreased cellular viability (Figure S2E; Arocena et al., 2005; Handa et al., 2005; Sellier et al., 2010) .
RAN Translation of Polyglycine Protein Initiates 5
0 to the CGG Repeat To elucidate the mechanism by which RAN translation initiation occurs, we created a series of mutations in the sequence 5 0 to the repeat to determine the minimal requirements for initiation. We first introduced a stop codon at À6 bp, À12 bp, À21 bp, or À63 bp from the start of the CGG repeat ( Figure 3D ). Stop codons placed at À6 bp or À12 bp prevented the appearance of GFP-positive inclusions and HMW GFP ( Figures 3D-3F ). In contrast, placement of a stop codon at À21 or À63 bp did not block production of HMW GFP, suggesting that RAN translation initiates between 21 and 12 bases 5 0 of the CGG repeat ( Figure 3D ).
The bias toward translation in the glycine reading frame suggested preferred initiation at a specific non-AUG start site. A plausible explanation is the use of a specific alternative start codon as the translational origin rather than initiation within the hairpin itself. However, serially mutating each potential alternative start codon (i.e., ''near-AUG'' codons, differing by a single base from AUG) in the glycine frame within 60 bp 5 0 of the CGG repeat did not eliminate production of HMW GFP ( Figure 3G and data not shown). This result suggests either that a near-AUG codon is not needed to initiate translation or that multiple, different near-AUG codons proximal to the repeat can be utilized, so that eliminating any one near-AUG codon is not sufficient to prevent translation. To address this latter possibility, we placed a stop codon at À21 bp, which by itself does not prevent production of HMW GFP ( Figure 3H) , and mutated the only potential near-AUG codon downstream of this stop codon, a GUG codon at À11 bp. Mutating this GUG codon to GAG by itself had no impact on HMW GFP production but, combined with the stop codon at À21, HMW GFP production was lost ( Figure 3H ). This result suggests that, at least for some sequence contexts, a near-AUG codon close to the repeat is required for CGG RAN translation initiation, but the specific sequence 5 0 to the repeat is less critical. To evaluate this, we deleted 48 nt just 5 0 proximal to the CGG repeat, which impaired production of HMW GFP ( Figure 3I ). Deleting 91 nt 5 0 proximal to the repeat nearly eliminated HMW GFP production, which could reflect the importance of the specific sequence just proximal to the repeat or represent a consequence of shortening the distance between the transcription start site and the repeat ( Figure 3I ). Table S1 . **p < 0.001 for trend, one-way ANOVA, *p < 0.001 versus GFP, yp < 0.001 versus (CGG) 88 +1 GFP, t test. For (C) and (F), error bars represent SEM.
RAN Translation Also Occurs in the Alanine Reading
Frame RAN translation associated with CGG repeats was not restricted to the glycine frame. In the +2 (GCG, alanine-encoding) frame, removing an in-frame stop codon between the repeat and the GFP coding sequence led to an HMW GFP band and aggregated protein ( Figures 4A and 4B ), although GFP-positive inclusions were not seen in transfected cells ( Figure 4C ). The +2 (Ala) frame HMW GFP species electrophoreses as a slightly smaller protein than what is seen with identical sized repeats in +1 (Gly) frame constructs, suggesting a different site of initiation ( Figure 4B ). In contrast to our results in the +1 (Gly) frame, reducing the repeat size to 30 CGGs eliminated expression of HMW GFP in the +2 (Ala) frame ( Figure 4D ). When a stop codon was introduced in the +2 (Ala) frame at À8 bp from an expanded (CGG) 88 repeat, expression of the HMW GFP persisted (Figure 4E ). This result could reflect translational initiation in the +1 (Gly) frame followed by a frameshift into the +2 (Ala) frame, as frameshifts are known to occur with longer CAG repeat expansions (Stochmanski et al., 2012) . To test this possibility, we introduced an upstream stop codon (À6 bp) in the +1 (Gly) frame while placing the downstream GFP sequence in the +2 (Ala) frame. This did not eliminate expression of an HMW GFP product ( Figure 4E ). To further exclude a Gly to Ala frame shift, we incubated lysates from cells expressing (CGG) 88 +1 GFP or (CGG) 88 +2 GFP with lysostaphin. Lysostaphin degraded HMW GFP produced in the +1 (Gly) frame but not in the +2 (Ala) frame ( Figure 4F ). We conclude that RAN translation associated with CGG repeats in the FMR1 5 0 UTR occurs in at least two of three possible reading frames, but the constraints on translational initiation appear to differ for these two frames.
The FMR1 5
0 UTR Is Engaged with Translating Ribosomes CGG RAN translation in Drosophila and transfected mammalian cells suggests that unconventional translation may also occur in FXTAS patients. To explore this possibility, we first assessed whether the 5 0 UTR of FMR1 mRNA is associated with translating ribosomes by querying ribosome profiling data sets previously generated in human cell lines (Guo et al., 2010; Hsieh et al., 2012; Ingolia et al., 2012) . This technique combines ribosomal foot printing with next-generation sequencing to identify sites of active translation. In examining the distribution of ribosomes on FMR1 mRNA in published data sets, we observed that most sequence reads occurred, as expected, over coding regions of the FMR1 mature mRNA sequence ( Figure 5A ), with few if any reads in introns or the 3 0 UTR. However, in the 5 0 UTR of FMR1 mRNA, two peaks of protected sequence were present in the region just 5 0 to the CGG repeat ( Figure 5A ), suggesting that fully assembled translating ribosomes do reside in this region of FMR1 RNA in human cells. These peaks exhibited $40% of the mean read coverage and 60% of the peak read coverage observed in the first coding exon of FMR1 and were consistent across three published data sets in different human cell lines (Hsieh et al., 2012; Ingolia et al., 2012) . Analysis of three mouse cell line data sets revealed a similar set of peaks just 5 0 to the CGG repeat ( Figures S4C and S4D) (Guo et al., 2010; Ingolia et al., 2011; Lee et al., 2012; Thoreen et al., 2012) .
Data from studies utilizing the translational inhibitor Herringtonine to stall ribosomes at initiation suggest that many transcripts contain active upstream ORFs with initiation at alternative translational initiation sites (aTISs) ( Figure S4 ) (Fritsch et al., 2012; Ingolia et al., 2011) . Consistent with this observation, the average read density over the FMR1 5 0 UTR was comparable to the majority of transcripts across data sets in both human and mouse samples. We therefore focused our attention on the enhanced read density over near-AUG codons just 5 0 proximal to the repeat, given that our cell culture data was most consistent with initiation in this region. We reasoned that enhanced read density could represent pausing of assembling ribosomes at initiation sites (Ingolia et al., 2011) . The read density over two specific near-AUG codons (iGTG 12 nt 5 0 to the repeat and iCTG 24 nt 5 0 to the repeat) was significantly enhanced compared to other nucleotide triplets within the FMR1 5 0 UTR (Figures S4A and S4B) . Similarly, the mouse fmr1 5 0 UTR also exhibited peaks of increased RP read density just 5 0 proximal to the repeat that correlated with Herringtonine-identified initiation sites at near-AUG codons ( Figures S4C and S4D) . When compared to the distribution of read densities within 5 0 UTRs on a transcriptome-wide level, these sites within the FMR1/ fmr1 5 0 UTR demonstrate relative read densities that are comparable to Herringtonine-confirmed alternative translational initiation sites ( Figures S4E-S4G ). Taken together, these data are consistent with translational initiation within the 5 0 UTR of FMR1/fmr1 just proximal to the CGG repeat.
The FMR1 Polyglycine Protein Is Present in FXTAS Patient Brains
Translation of a 90 CGG repeat-containing FMR1 mRNA is predicted to produce an 11.5 kDa protein that contains an N-terminal polyglycine stretch followed by a 42 amino acid carboxyl terminal domain out of frame with the downstream FMRP start codon; we named this predicted protein FMRpolyG ( Figure 5B ). To determine whether FMRpolyG is made in FXTAS patients, we developed a monoclonal antibody (2J7) against a peptide from the predicted human protein ( Figure 5B ). Tested against recombinant FMRpolyG generated in bacteria as a GST-HIS fusion, 2J7 recognized two bands in bacterial lysates and purified protein samples ( Figure 5C ) that were confirmed by tandem MS to be FMRpolyG. In transfected mammalian cells expressing a FLAG-tagged FMRpolyG with 55 repeats, both 2J7 and FLAG antibody detected a protein electrophoresing at a slightly higher than expected MW of $16 kDa ( Figure 5D ). In transfected COS cells, FLAG-FMRpolyG 55 displayed diffuse nucleocytoplasmic staining with occasional intranuclear inclusions detected by immunofluorescence with either 2J7 or anti-FLAG antibodies ( Figure 5E ). 2J7 immunostaining also colocalized with GFP inclusions formed in cells expressing FMRpolyG 100 -GFP ( Figure 5F ). In contrast and as expected, 2J7 staining did not colocalize with GFP or inclusions in cells expressing an expanded polyglutamine-GFP fusion ( Figure 5F ).
To evaluate whether FMRpolyG is expressed in FXTAS patient brains, we performed western blots on cerebellar lysates from FXTAS patients. In pathologically confirmed FXTAS cases, an $15 kDa band was identified in FXTAS lysates but not in control or AD brain lysates ( Figure 5G , Figure S5E ). We next evaluated whether this antibody differentially immunostained brain tissue from patients with clinically and pathologically confirmed FXTAS. Immunostaining with 2J7 was much more robust in FXTAS patient-derived hippocampal sections than in control tissue sections and included nuclear and perinuclear aggregates in FXTAS sections not seen in controls ( Figure 5H , Figure S5A ). In FXTAS hippocampus, numerous ubiquitin-positive inclusions were observed ( Figure S6B ), consistent with previous reports , and these inclusions coimmunostain with 2J7 ( Figure 5I, Figures S5B-S5D ). In contrast, 2J7 did not immunostain ubiquitinated polyglutamine inclusions in SCA 3 patient tissues ( Figure 5I, Figure S6E ). Similar staining by western blot and immunohistochemistry was observed using a different monoclonal antibody (2C13) against an overlapping epitope ( Figures S5F-S5L) .
We also generated an additional rabbit polyclonal antibody Ab605 raised against a larger peptide fragment of FMRpolyG ( Figure 5B ). This antibody also recognizes the recombinant protein ( Figure 5J ). To evaluate whether Ab605 recognizes FMRpolyG in inclusions in tissue, we first tested it on transverse retinal sections of Drosophila expressing the full antibody epitope. In flies expressing (CGG) 90 GFP, Ab605 readily colocalized with GFP+ inclusions ( Figure S6A ) but showed minimal staining in flies expressing GFP alone ( Figure S6A ). Whereas in control human tissue Ab605 displayed mild diffuse staining not seen in preimmune controls, Ab605 robustly stained neurons and intranuclear inclusions in FXTAS brain ( Figure 5K , Figure S6C ). By immunofluorescence, Ab605 staining colocalized with ubiquitin in FXTAS brain tissue ( Figure S6D ). Recognition of FXTAS inclusions was specific, as there was no staining by Ab605 of ubiquitinated polyglutamine inclusions in tissue sections from a spinocerebellar ataxia 3 brain ( Figure S6E ).
RAN Translation of the Polyglycine Protein Explains the Difference in Inclusion Formation between Two Mouse Models of FXTAS
To gauge the functional consequence of expressing a cryptic polyglycine protein, we turned to two similar mouse models of FXTAS. In both models, one generated in the Netherlands (Willemsen et al., 2003) and the other at the NIH (Entezam et al., 2007) , premutation repeats were inserted into the 5 0 UTR of the mouse fmr1 locus. Both knockin (KI) models demonstrate intragenerational repeat instability and some evidence of neurodegeneration, but their phenotypes have not been directly compared (Brouwer et al., 2008) . Comparing the cloning strategies used to make both lines, we noted that the NIH mouse model retains a greater region of mouse 5 0 UTR surrounding the CGG repeat, including a TAA stop codon 18 bp 5 0 of the repeat in the glycine frame ( Figure 6A ). This stop codon is not present in the Dutch knockin mouse or in humans. In cell culture experiments, placing the NIH mouse sequence, but not the Dutch mouse sequence, just proximal to the repeat blocked translation in the +1 (Gly) frame ( Figure 6B ). Thus, we would predict expression of the novel polyglycine protein only in the Dutch knockin mouse. Consistent with this prediction, 18-month-old mice from both lines differ greatly in the number and distribution of ubiquitinated inclusions. In Dutch knockin mice, ubiquitin-positive inclusions accumulate in the hypothalamus, cortex, and brainstem ( Figures 6C and 6D ) as previously reported (Brouwer et al., 2008) , whereas they were seen less frequently in NIH knockin mice ( Figures 6C and 6D ). This difference exists despite similar expression of (CGG) n fmr1 RNA in both models ( Figure 6E) . (legend continued on next page)
Neuron
RAN Translation in FXTAS
Because Ab605 was raised against a peptide sequence largely conserved in mouse, we used it to determine whether there is divergent immunostaining for FMRpolyG protein in the two models. Again, Dutch knockin mice show much greater immunostaining for FMRpolyG, including punctate nuclear staining consistent with inclusions in brain regions that also display ubiquitin-positive inclusions (Figures 6F and 6G) . By coimmunofluorescence, Ab605 staining for FMRpolyG in Dutch knockin mice colocalized with ubiquitin-positive inclusions ( Figure 6H ). Together, these data suggest a dissociation of pathology in the two models based on differences in the ability to generate the polyglycine protein.
Translation of the Polyglycine Protein Contributes to CGG Repeat Toxicity in Human Cell Lines and Drosophila
The above results demonstrating RAN translation of a polyglycine protein in FXTAS models and patients support a role for FMRpolyG in aggregate formation in FXTAS. A critical, unanswered question is whether this polyglycine protein contributes to disease pathogenesis in FXTAS, or whether instead the CGG repeat as mRNA is wholly responsible for repeat-associated neurodegeneration. We therefore evaluated the effect of driving translation through the repeat on cell viability. Compared to expression of GFP alone, (CGG) 88 +1 GFP expression was associated with increased cell death at 72 hr, as measured by propidium iodide exclusion in GFP-positive cells ( Figure 7A ). This toxicity was repeat length dependent ( Figure S2E ), consistent with previous reports (Arocena et al., 2005; Sellier et al., 2010) . When translation of the polyglycine protein was enhanced by placing an ATG upstream of the repeat, which increases production of the polyglycine protein without altering (CGG) GFP mRNA levels, the toxicity of the construct increased further ( Figure 7A ).
Because introducing a stop codon just before the repeat eliminated production of HMW GFP, we reasoned that this construct might allow us to determine whether initiating RAN translation is required for repeat-associated toxicity. Computer modeling of the FMR1 5 0 UTR RNA secondary structure predicts an energetically favorable hairpin that includes the CGG repeat ( Figure S3 ; Napierala et al., 2005) . Placement of a stop codon at À12 bp relative to the repeat is not predicted to disrupt this hairpin (Figure S3) , suggesting that CGG repeat structure should be preserved in this construct. We therefore measured cell death in transfected cells expressing (CGG) 88 +1 GFP or a similar (CGG) 94 +1 GFP construct containing a stop codon 12 bp before the repeat. Inclusion of this stop codon suppressed toxicity associated with the CGG repeat expansion, suggesting that a component of repeat toxicity reflects production of a polyglycine protein ( Figure 7A ).
To evaluate these effects in vivo, we generated a series of Drosophila lines in which the repeat was placed in different sequence contexts relative to GFP ( Figure 7B , Table S2 ). We first regenerated lines in which the CGG repeat in the 5 0 UTR of FMR1 is inserted upstream of GFP in the +1 (Gly) reading frame. In other lines, we inserted an ATG and FLAG tag just upstream of the CGG repeat to maximally drive expression of the polyglycine protein. To generate constructs in which the CGG repeat would be present as RNA but not translated into protein, we took two approaches: (1) inserting a stop codon 12 nt 5 0 of the CGG repeat to prevent repeat-associated translation of the polyglycine protein, as shown earlier in cell culture ( Figure 3D ), or (2) moving the CGG repeat and surrounding regions of the 5 0 UTR to a position downstream of GFP in the 3 0 UTR. In cell culture, this repositioning blocked RAN translation ( Figure 7C ). All Drosophila lines expressed 100 CGG repeats, which were stable with intergenerational transmission.
Differential placement of the CGG repeat modestly altered transcript expression in Drosophila, with increased GFP mRNA in lines containing the repeat in the 5 0 UTR (Figure S7A ), perhaps due to local chromatin effects (Todd et al., 2010) . Accordingly, we chose for further analysis lines in which GFP RNA production was comparable ( Figure S7A) . At the protein level, placing the CGG repeat in the 5 0 UTR led to less overall GFP translation than did placement in the 3 0 UTR ( Figure 7D ). As expected, including an ATG start codon upstream of the repeat led to increased production of HMW GFP but decreased production from the canonical TIS of GFP ( Figure 7D) .
To determine the impact of polyglycine protein expression on neurodegenerative phenotypes, we expressed each transgene in retinal oomatidia. In flies expressing the repeat in the 5 0 UTR, we again observed the appearance of ubiquitin-positive GFP inclusions, which occurred more frequently when an ATG was placed upstream of the repeat ( Figure 7E ). In lines with a stop codon 5 0 to the repeat or with the repeat positioned in the 3 0 UTR, there were no GFP inclusions. We next determined whether expression of these different transgenes elicited a rough-eye phenotype as a measure of toxicity. Placing the repeat in the 5 0 UTR and in-frame with GFP resulted in a moderate rough-eye phenotype ( Figures 7F,  7G , and S8C), but this same repeat elicited only a very mild rough-eye phenotype when inserted into the 3 0 UTR of GFP. Similarly, inserting a stop codon just 5 0 to the repeat suppressed toxicity ( Figures 7F, 7G, and S7C) . In contrast, when an ATG was included 5 0 to the repeat to drive polyglycine production, the rough-eye phenotype was more severe (Figures 7F and 7G) . These results were consistent across multiple insertion lines ( Figure S7C ). When expressed ubiquitously, a CGG repeat placed in the 5 0 UTR of GFP led to a decrease in viable progeny, and inclusion of an ATG 5 0 of the repeat further enhanced this toxicity ( Figure 7H ). In contrast, including a stop codon 5 0 of the repeat or placing the repeat in the 3 0 UTR prevented CGG repeat-associated alterations in viability ( Figure 7H ). Together, these results suggest that RAN translation of a polyglycine protein contributes to CGG repeat toxicity in Drosophila.
DISCUSSION
Our results demonstrate that RAN translation occurs in association with CGG repeats in the neurodegenerative disorder FXTAS, a disease previously thought to result primarily from RNAmediated toxicity. These findings, along with recent reports detailing unconventional translation through CAG repeats in spinocerebellar ataxia type 8 and myotonic dystrophy type I (Zu et al., 2011) and GGGGCC repeats in C9orf72-associated ALS/FTLD (Ash et al., 2013; Mori et al., 2013) , suggest that RAN translation is a shared pathogenic mechanism in many repeat expansion disorders. We further demonstrate that production of one particular CGG RAN translation product in FXTAS, FMRpolyG, directly modulates CGG-associated pathology in two distinct model systems. First, the ability to generate the FMRpolyG protein explains a key pathologic discrepancy between two established knockin mouse models. Second, in Drosophila we demonstrate that CGG repeat-associated neurodegeneration is largely dependent on FMRpolyG production. These results suggest that RAN translation contributes to FXTAS pathogenesis ( Figure 8 ) and support an emerging view that nonexonic repetitive elements can trigger toxicity simultaneously as both RNA and protein.
The mechanisms underlying RAN translation remain unclear. The unconventional translation described here appears to initiate predominantly at a near-AUG codon just 5 0 proximal of the repeat. This finding suggests a model wherein a scanning 43S ribosomal preinitiation complex stalls at the CGG repeat, allowing for alternate usage of a near match at the initiation codon (Figure 8 ). This model is based on our observation that placing a stop codon just proximal to the repeat or shortening the 5 0 leader before the repeat impairs RAN translation in this reading frame (Figure 3) . In contrast, CGG RAN translation in the other two possible reading frames behaves differently. We do not detect any RAN translation product from the +0 (CGG, polyArginine) reading frame, and RAN translation in the +2 (GCG, polyAlanine) reading frame is less efficient, occurs when stop codons are inserted 5 0 of the repeat, and demonstrates CGG repeat length dependence (Figures 3, 4 , and 5). Differences in the propensity for translational initiation in different reading frames were also reported for RAN translation of expanded Table S2 . Boxed red X, stop codon; green, GFP; red, CGG repeat; blue, other sequence; yellow, epitope tag (Flag or 6xHis tag).
(C) Placing the CGG repeat in the 3 0 UTR of GFP eliminates the RAN translation product. COS cells were transiently transfected with either GFP (À control), ATG-FLAG-(CGG) 100 +1 GFP (+ control), or GFP-STOP-(CGG) 100 -FLAG and total lysates were harvested. Blots were serially probed with antibodies to FLAG, GFP, and actin. (legend continued on next page) Neuron RAN Translation in FXTAS CAG repeats in SCA 8, in which the surrounding sequence appeared to be an important modulator (Zu et al., 2011) . Thus, RAN translation may not result from a single mechanism. Rather, each repeat, and indeed each reading frame within each repeat, may have different contextual requirements. These differences notwithstanding, the fact that atypical translation has now been observed independently with four different nucleotide RNA repeats in cell lines, animal models, and human tissues suggests that it is a more widespread biological event than anticipated. An emerging question now is what roles do these translation initiation events play in normal physiology and in disease? Our findings support a significant role for the FMRpolyG protein in disease pathogenesis, given the evidence in Drosophila and mammalian cells of enhanced toxicity with increased polyglycine translation and lessened toxicity when translation is reduced. However, numerous published studies support a primary role for CGG RNA in toxicity (Arocena et al., 2005; Hashem et al., 2009; Jin et al., 2007; Sellier et al., 2010; Sofola et al., 2007) , leading us to suggest that, in FXTAS, additive or synergistic toxicity associated with both toxic RNA and toxic proteins may be critical to disease pathogenesis. Though we have focused on FMRpolyG production, other CGG RAN translationassociated products such as the polyalanine protein could represent additional toxic species. Moreover, if RAN translation occurs with CCG repeats, then production of other homopolymeric proteins from the antisense transcript through the repeat could also be relevant (Ladd et al., 2007) . For all of these potentially toxic entities, it will be important to determine their relative production in patients and relative degree of toxicity in animal models to ascertain their roles in disease pathogenesis.
CGG RAN translation may also play a normal physiological role in translational regulation of FMR1 mRNA. FMRP, the protein product of FMR1, critically regulates synaptic function and its loss leads to fragile X syndrome, a common cause of autism and mental retardation. FMR1 mRNA is rapidly translated at synapses in an activity-dependent manner, where it constrains local synaptic protein translation (Penagarikano et al., 2007) . Our results in transfected cells show that RAN translation can occur at normal repeat sizes, with initiation occurring within a narrow region just 5 0 of the repeat (Figure 8 ). Analysis of ribosomal profiling data sets derived from samples with normal CGG repeat sizes demonstrates the presence of assembled ribosomes over these regions in both human and mouse cell lines (Figures 5 and S5 ; Ingolia et al., 2011) . Intriguingly, the Drosophila homolog of FMRP, dfxr, is expressed as two isoforms, with the larger isoform initiating translation at a CUG codon upstream of the canonical TIS, indicating that aspects of this process may be evolutionarily conserved (Beerman and Jongens, 2011) . Upstream ORFs are believed to suppress expression from downstream canonical ORFs (Chatterjee and Pal, 2009 ). In the case of FMR1 mRNA, translation through the repeat may assist RNA unwinding via helicase recruitment, allowing normal scanning by trailing ribosomes and appropriate initiation at the canonical ORF (Figure 8 ). Alternatively, ribosomes translating through the repeat could terminate translation and reinitiate at the AUG of FMRP, or ribosomes could initiate downstream of the repeat via an internal ribosomal entry site (Ludwig et al., 2011) .
Variations on the RAN translation described here potentially could expand the percentage of the transcriptome encoding for protein, complicating the classical definitions by which we divide ''coding'' from ''noncoding'' RNA. Consistent with this, recent unbiased methods in yeast and mammalian cells reveal that thousands of transcripts initiate translation at non-AUG start sites, often creating upstream ORFs in sequences previously identified as 5 0 UTR (Ingolia et al., 2011; Ivanov et al., 2011) . Usage of these atypical upstream ORFs is responsive to changes in cell state and external stimuli . Mechanisms similar to those reported here may therefore have broader repercussions for the neuronal proteome and global translational regulation.
EXPERIMENTAL PROCEDURES Fly Stocks
Drosophila lines used in Figures 1 and S1 of this study have been previously described in Jin et al. (2003) , Pandey et al. (2007) , and Todd et al. (2010) . Details of construction of new fly lines are in the Supplemental Experimental Procedures and Table S2 . Unless stated otherwise, all crosses were done and maintained on standard food at 25 C. For (CGG) 90 GFP lines, stability of the CGG repeat was confirmed by PCR and sequencing using C and F primers.
Plasmid Constructs for Cell Culture Experiments
Cell culture expression plasmids were derived from CMV-(CGG) 88 -GFP, a kind gift from Paul Hagerman (Arocena et al., 2005) or were PCR cloned from patient-derived cell lines. Sequence variants were generated from this vector by site-directed mutagenesis (Stratagene) according to manufacturer's protocols. All vector sequences were confirmed by Sanger sequencing and are described in detail in Table S1 .
Lysostaphin Protease Digestion
Immunoprecipitation with anti-GFP agarose beads was conducted as described in the Supplemental Experimental Procedures. Prior to elution, the beads were washed 23 in RIPA without protease inhibitors and then in 20 mM Tris-HCl buffer at pH 7.5 without protease inhibitors. The agarose beads were then incubated with 0.1 mg/ml Lysostaphin (Sigma) in Tris buffer or in Tris buffer alone with agitation at room temperature for 3 or 20 hr. The beads were then washed 1 3 5 min with RIPA buffer and eluted with Laemmli buffer.
Antibody Generation
Monoclonal mouse antibodies 2J7 and 2C13 were developed commercially (Abmart) against a 10 amino acid peptide, LAGLKRRWRS, in the predicted carboxyl terminus of the FMR1polyG. The epitope is predicted to be present in human patient samples, with a near match (8/10 AA) to the original (CGG) 90 GFP Drosophila lines, but not the newly constructed Drosophila lines or the transfection vector constructs used in Figures 2, 3 , and 4. The epitope is effectively absent (5/10 AA match) from both mouse KI models. Rabbit polyclonal antibody Ab605 was generated commercially (Rockland) against a larger peptide (GLKRRWRSWWWKCGAP) that overlaps more significantly with the predicted sequence in Drosophila (16/17) and in both mouse lines (13/17).
Human Tissue
All human tissues were obtained and distributed under oversight by appropriate institution specific review boards. Detailed methods and descriptions of the patient derived samples are included in the Supplemental Experimental Procedures. Briefly, hippocampal, cerebellar, and frontal cortex tissue from two previously described FXTAS patients (Louis et al., 2006) and age-and sex-matched controls (University of Michigan Alzheimer's Disease Brain Bank) were processed using standard techniques. CGG repeat size was determined in both controls and FXTAS patients by DNA isolation followed by PCR using C and F primers. 
Statistical Analysis
